Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 DiabetesThe New England journal of medicine, 2020-06, Vol.382 (26), p.2493-2503 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1916624 ;PMID: 32579810Full text available |
|
2 |
Material Type: Article
|
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with GoutThe New England journal of medicine, 2018-03, Vol.378 (13), p.1200-1210 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1710895 ;PMID: 29527974Full text available |
|
3 |
Material Type: Article
|
Effects of Allopurinol on the Progression of Chronic Kidney DiseaseThe New England journal of medicine, 2020-06, Vol.382 (26), p.2504-2513 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1915833 ;PMID: 32579811Full text available |
|
4 |
Material Type: Article
|
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) StudyCirculation (New York, N.Y.), 2015-05, Vol.131 (20), p.1763-1771 [Peer Reviewed Journal]2015 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.114.014536 ;PMID: 25986447Full text available |
|
5 |
Material Type: Article
|
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)Annals of the rheumatic diseases, 2017-05, Vol.76 (5), p.811-820 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2016-209213 ;PMID: 27821644 ;CODEN: ARDIAOFull text available |
|
6 |
Material Type: Article
|
A Randomized, Double‐Blind, Active‐ and Placebo‐Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With GoutArthritis & rheumatology (Hoboken, N.J.), 2016-08, Vol.68 (8), p.2027-2034 [Peer Reviewed Journal]2016 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of the American College of Rheumatology. ;2016, American College of Rheumatology ;ISSN: 2326-5191 ;EISSN: 2326-5205 ;DOI: 10.1002/art.39684 ;PMID: 26989892Full text available |
|
7 |
Material Type: Article
|
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular RiskClinical journal of the American Society of Nephrology, 2010-08, Vol.5 (8), p.1388-1393 [Peer Reviewed Journal]Copyright © 2010 by the American Society of Nephrology ;ISSN: 1555-9041 ;EISSN: 1555-905X ;DOI: 10.2215/CJN.01580210 ;PMID: 20538833Full text available |
|
8 |
Material Type: Article
|
Allopurinol treatment improves renal function in patients with type 2 diabetes and asymptomatic hyperuricemia: 3-year randomized parallel-controlled studyClinical endocrinology (Oxford), 2015-10, Vol.83 (4), p.475-482 [Peer Reviewed Journal]2014 John Wiley & Sons Ltd ;2014 John Wiley & Sons Ltd. ;Copyright © 2015 John Wiley & Sons Ltd ;ISSN: 0300-0664 ;EISSN: 1365-2265 ;DOI: 10.1111/cen.12673 ;PMID: 25400252Full text available |
|
9 |
Material Type: Article
|
Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic HyperuricemiaJournal of investigative medicine, 2015-12, Vol.63 (8), p.924-929 [Peer Reviewed Journal]2015 American Federation for Medical Research, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 American Federation for Medical Research ;Copyright: 2015 (c) 2015 American Federation for Medical Research, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 1081-5589 ;EISSN: 1708-8267 ;DOI: 10.1097/JIM.0000000000000242 ;PMID: 26571421Full text available |
|
10 |
Material Type: Article
|
Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled TrialJournal of the American Society of Nephrology, 2024-05, Vol.35 (5), p.594-606 [Peer Reviewed Journal]EISSN: 1533-3450 ;DOI: 10.1681/ASN.0000000000000326 ;PMID: 38564654Full text available |
|
11 |
Material Type: Article
|
Vascular Function and Uric Acid-Lowering in Stage 3 CKDJournal of the American Society of Nephrology, 2017-03, Vol.28 (3), p.943-952 [Peer Reviewed Journal]Copyright © 2017 by the American Society of Nephrology. ;Copyright © 2017 by the American Society of Nephrology 2017 ;ISSN: 1046-6673 ;EISSN: 1533-3450 ;DOI: 10.1681/asn.2016050521 ;PMID: 27620990Full text available |
|
12 |
Material Type: Article
|
Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney diseaseJournal of the American Society of Nephrology, 2011-07, Vol.22 (7), p.1382-1389 [Peer Reviewed Journal]Copyright © 2011 by the American Society of Nephrology ;Copyright © 2011 by the American Society of Nephrology 2011 ;ISSN: 1046-6673 ;EISSN: 1533-3450 ;DOI: 10.1681/ASN.2010111185 ;PMID: 21719783Full text available |
|
13 |
Material Type: Article
|
Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysisRheumatology (Oxford, England), 2017-07, Vol.56 (7), p.1144-1153 [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/kex065 ;PMID: 28379501Full text available |
|
14 |
Material Type: Article
|
One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout studyArthritis research & therapy, 2022-04, Vol.24 (1), p.88-88, Article 88 [Peer Reviewed Journal]2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-022-02772-3 ;PMID: 35443675Full text available |
|
15 |
Material Type: Article
|
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trialArthritis research & therapy, 2010-01, Vol.12 (2), p.R63-R63 [Peer Reviewed Journal]COPYRIGHT 2010 BioMed Central Ltd. ;Copyright ©2010 Becker et al.; licensee BioMed Central Ltd. 2010 Becker et al.; licensee BioMed Central Ltd. ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/ar2978 ;PMID: 20370912Full text available |
|
16 |
Material Type: Article
|
Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort studyRheumatology (Oxford, England), 2019-12, Vol.58 (12), p.2122-2129 [Peer Reviewed Journal]The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/kez189 ;PMID: 31098635Full text available |
|
17 |
Material Type: Article
|
Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease-Related Medications in VeteransClinical journal of the American Society of Nephrology, 2019-12, Vol.14 (12), p.1773-1780 [Peer Reviewed Journal]Copyright © 2019 by the American Society of Nephrology. ;Copyright © 2019 by the American Society of Nephrology 2019 ;ISSN: 1555-9041 ;EISSN: 1555-905X ;DOI: 10.2215/CJN.03580319 ;PMID: 31712387Full text available |
|
18 |
Material Type: Article
|
Impact of allopurinol on risk of myocardial infarctionAnnals of the rheumatic diseases, 2015-05, Vol.74 (5), p.836-842 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2012-202972 ;PMID: 24395556 ;CODEN: ARDIAOFull text available |
|
19 |
Material Type: Article
|
The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patientsArthritis research & therapy, 2019-03, Vol.21 (1), p.77-77, Article 77 [Peer Reviewed Journal]COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-019-1860-8 ;PMID: 30894219Full text available |
|
20 |
Material Type: Article
|
Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug responseClinical pharmacology and therapeutics, 2015-05, Vol.97 (5), p.518-525 [Peer Reviewed Journal]2015 American Society for Clinical Pharmacology and Therapeutics ;2015 American Society for Clinical Pharmacology and Therapeutics. ;ISSN: 0009-9236 ;EISSN: 1532-6535 ;DOI: 10.1002/cpt.89 ;PMID: 25676789Full text available |